Testogel Dosiergel, transdermales Gel
7680692520029
CH-69252
Gel
Associated product:
TESTOGEL gel doseur 16.2 mg/g réc multidose 2 pce
1 / 3
google
Article details
- Package size
- 2
- Selling units
- 2
- Measure
- Stück
- Galenic form
- Gel
- Galenic group
- Salben
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
16.2 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
725.7 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Vifor (International) Inc.
9014 St. Gallen
Authorization information
- Swissmedic authorization number
- 69252
- Drug name
- Testogel Dosiergel, transdermales Gel
- Galenic form
- TRDG
- ATC Code
- G03BA03
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 19/11/2024
- Authorization expiration date
- 18/11/2029
- IT Number
- 07.08.4.
- Domain
- Human medicine
Package details
- Description (FR)
- TESTOGEL gel doseur 16.2 mg/g réc multidose 2 pce
- Description (DE)
- TESTOGEL Dosiergel 16.2 mg/g Mehrdosenbeh 2 Stk
- Market launch
- 19/11/2024
- Narcotic (BTM)
- No